A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Mechlorethamine
Ethylmorphine
The risk or severity of adverse effects can be increased when Pancuronium is combined with Ethylmorphine.
Mechlorethamine
Diamorphine
The risk or severity of adverse effects can be increased when Pancuronium is combined with Diamorphine.
Mechlorethamine
Dihydroetorphine
The risk or severity of adverse effects can be increased when Pancuronium is combined with Dihydroetorphine.
Mechlorethamine
Methadyl acetate
The risk or severity of adverse effects can be increased when Pancuronium is combined with Methadyl acetate.
Mechlorethamine
Dezocine
The risk or severity of adverse effects can be increased when Dezocine is combined with Pancuronium.
Mechlorethamine
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Pancuronium.
Mechlorethamine
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Pancuronium.
Mechlorethamine
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Pancuronium.
Mechlorethamine
Desomorphine
The risk or severity of adverse effects can be increased when Desomorphine is combined with Pancuronium.
Mechlorethamine
Levacetylmethadol
The risk or severity of adverse effects can be increased when Pancuronium is combined with Levacetylmethadol.
Mechlorethamine
Alaproclate
The risk or severity of adverse effects can be increased when Pancuronium is combined with Alaproclate.
Mechlorethamine
Ritanserin
The risk or severity of adverse effects can be increased when Pancuronium is combined with Ritanserin.
Mechlorethamine
Indalpine
The risk or severity of adverse effects can be increased when Pancuronium is combined with Indalpine.
Mechlorethamine
Levomilnacipran
The risk or severity of adverse effects can be increased when Pancuronium is combined with Levomilnacipran.
Mechlorethamine
Seproxetine
The risk or severity of adverse effects can be increased when Pancuronium is combined with Seproxetine.
Mechlorethamine
Desvenlafaxine
The risk or severity of adverse effects can be increased when Pancuronium is combined with Desvenlafaxine.
Mechlorethamine
Milnacipran
The risk or severity of adverse effects can be increased when Pancuronium is combined with Milnacipran.
Mechlorethamine
Dapoxetine
The risk or severity of adverse effects can be increased when Pancuronium is combined with Dapoxetine.
Mechlorethamine
Zimelidine
The risk or severity of adverse effects can be increased when Pancuronium is combined with Zimelidine.
Mechlorethamine
Sibutramine
The risk or severity of adverse effects can be increased when Pancuronium is combined with Sibutramine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3